In gene therapy, progress depends on decisions that are rarely simple. Developers feel this every day.

The right partnerships make those decisions easier. The wrong ones do the opposite. At Dyno Therapeutics, we have learned that partnerships benefit from principles that deliberately shape how we act when the work gets hard. In this post, I share the principles and a real moment when they turned a difficult decision into a stronger partnership.

Dyno’s Partnership Success Principles

Developer-First Ecosystem. Everything starts with the gene therapy developer. These are the teams doing the hard work of delivering new therapeutic options for patients. We cultivate an ecosystem that helps them move faster with less cost and risk, and we measure our decisions by one question: “Does this increase the developer’s chance of success?”

Learn What Motivates. Alignment is not automatic. We stay curious about what motivates our partners and take the time to understand how they make decisions. When motivations align, we strengthen them. When they do not, we work to repair the gap. If it cannot be repaired, we reconsider the partnership.

Same Team, Same Goal. Partnerships only work when goals are aligned. Once we commit, we work as one team. With a common goal at the center, we invest time in building relationships and understanding the needs of everyone involved, so the benefits to all parties can be realized. The corollary is also true–if a partnership won’t lead to a great outcome for everyone involved, it isn’t a good fit.

Unexpected Transparency. Trust grows when information flows. We anticipate and meet the information needs of our partners before they ask, because we always assume best intent. We share what’s necessary for mutual success, while protecting proprietary information. Unexpected transparency means sharing relevant, critical information, even if it’s difficult, without withholding anything that could impact the success of the partnership. Below, I talk about an instance where we leaned on this principle to resolve a real dilemma with a partner.

Above and Beyond. When we can deliver more value, we do. These moments show that our commitment to a partner’s success is real. Obviously, we have to weigh real-world costs, but we believe that these unexpected moments of raising the bar will build confidence and create room for emergence and better collaboration.

Continuously Improve. Every partnership teaches us something. We look for those lessons and use them to improve how the partnership works and communicates, so we can reduce effort for both sides.

These principles are not slogans. They are used in real moments by real teams. They help us navigate uncertainty and make better decisions together.

A moment when the principles mattered

One of our partners approached us with a request. They wanted to know the identity of a human receptor that appeared central to the performance of several Dyno capsids they were evaluating and considering for licensing. This was not a casual question. Understanding the receptor would help them assess human translatability and make an informed decision. At the same time, the receptor insight was sensitive and enabling. It reflected years of work and was deeply connected to the strength of Dyno’s platform.

The request forced a real dilemma. If we declined, the partner would be left without the context they needed to confidently move forward. If we shared, we exposed proprietary information. This is a situation where many companies default to caution. Critical information stays locked inside, decisions drag on, and opportunities are squandered.

Our principles pointed us in a different direction.

Same Team, Same Goal reminded us that this was not a zero-sum question. Both sides wanted the same outcome: a therapy that worked. Unexpected Transparency challenged us to push past the instinct to protect and instead focus on sharing what was necessary for mutual success.

Because of these principles, we did not spend time debating whether to share. The question became how to share responsibly. With the partner we designed a solution that gave them the information they needed while putting safeguards in place. The receptor info was shared with controlled access inside both organizations. Sensitive details were partitioned appropriately. Both sides were comfortable with the approach.

The impact was immediate. Trust increased. A major uncertainty was removed from the partner’s evaluation. We moved faster because we did not stall on a decision that our principles had already made clear. Internally, the discussion strengthened shared understanding of how and why we use these principles, especially in difficult moments.

This was not the first time we leaned into transparency. We’ve made a principled stand to find ways for Unexpected Transparency across our partnerships, whether it was unfavorable data or an unexpectedly great capsid from outside of the collaboration scope that we knew a partner would be excited about. Sharing these results early helped both teams adjust quickly and avoid wasted time. Moments like these remind us that time saved also compounds: every day that we cut from internal debate, or that a partner saves by operating with the latest information, adds up to months redirected toward accelerating discovery.

Why this matters for the ecosystem we are building

These principles were originally designed for our founding research collaborations. Today they guide our decisions across a growing ecosystem of gene therapy developers and the manufacturers, service providers, and investors they depend upon. This growth makes these principles more relevant than ever as we work collectively towards realizing genetic agency: an individual’s ability to take action at the genetic level to live a healthier life.

At Dyno, partnerships are central to how we help developers create new options for patients. From our early research collaborations, the Dyno Frontiers Network, and our recent Genetic Agency Technology Conference (GATC), the Partnership Success Principles guide how we strengthen partnerships and cultivate an ecosystem while navigating challenging moments.

If these principles resonate, reach out to explore how we can build towards genetic agency together. We would welcome the conversation.